Development Level

Tbio 4 | 10,625
Tchem 2 | 1,890
Tdark 1 | 7,003

Disease

Cancer 6 | 2,346
ovarian cancer 5 | 8,484
psoriasis 4 | 6,685
Hypersensitivity reaction type II disease 3 | 235
Kidney disease 3 | 396
Neoplasm Metastasis 3 | 138
Rheumatoid Arthritis 3 | 1,160
Severe Combined Immunodeficiency 3 | 46
dermatomyositis 3 | 933
glioblastoma 3 | 5,572
ulcerative colitis 3 | 2,087
Anemia 2 | 252
Bladder Neoplasm 2 | 109
Breast cancer 2 | 3,094
Down syndrome 2 | 548
Duchenne muscular dystrophy 2 | 602
Finding of Mean Corpuscular Hemoglobin 2 | 14
Inflammatory bowel disease 2 | 142
Lung Neoplasms 2 | 171
Malaria 2 | 140
Multiple myeloma 2 | 1,327
Neoplasms, Experimental 2 | 33
Peripheral Neuropathy 2 | 303
Peripheral vascular disease 2 | 90
Vascular disease 2 | 281
Waldenstrons macroglobulinemia 2 | 765
active Crohn's disease 2 | 918
acute quadriplegic myopathy 2 | 1,157
astrocytic glioma 2 | 2,241
atypical teratoid / rhabdoid tumor 2 | 4,369
diabetes mellitus 2 | 1,663
ductal carcinoma in situ 2 | 1,745
ependymoma 2 | 2,514
gastric carcinoma 2 | 832
invasive ductal carcinoma 2 | 2,950
medulloblastoma, large-cell 2 | 6,234
non diabetic and post-ischemic heart failure 2 | 200
pilocytic astrocytoma 2 | 3,086
tuberculosis 2 | 1,557
AMYOTROPHIC LATERAL SCLEROSIS 1 1 | 49
Acquired immunodeficiency syndrome 1 | 164
Acute kidney injury 1 | 65
Adult T-Cell Lymphoma/Leukemia 1 | 30
Anorexia 1 | 15
Arsenic Poisoning 1 | 59
Autistic Disorder 1 | 320
Beta thalassemia 1 | 19
COPD 1 | 113
Celiac disease 1 | 112
Chronic Lymphocytic Leukemia 1 | 242
Colorectal Neoplasms 1 | 217
Common variable immunodeficiency 1 | 72
Dermatologic disorders 1 | 65
Diarrhea 1 | 155
Encephalitis 1 | 54
Esophageal Neoplasms 1 | 67
Exanthem 1 | 39
Fibrous dysplasia 1 | 15
Glioma 1 | 65
Glomerulonephritis 1 | 36
HIV Infections 1 | 100
Hepatitis C 1 | 90
Human immunodeficiency virus infectious disease 1 | 92
Hyperactive behavior 1 | 31
Hypotension 1 | 53
Infectious mononucleosis 1 | 15
Inflammation 1 | 109
Influenza 1 | 142
Iron metabolism disease 1 | 17
Kidney Neoplasm 1 | 27
Leukemia, Myelocytic, Acute 1 | 113
Leukopenia 1 | 42
Liver Cirrhosis 1 | 101
Liver neoplasms 1 | 109
Lymphatic system disease 1 | 14
Lymphoma, Non-Hodgkin 1 | 22
Lysinuric protein intolerance 1 | 15
Major Depressive Disorder 1 | 106
Mammary Neoplasms 1 | 410
Mammary Neoplasms, Experimental 1 | 150
Mastitis 1 | 48
Melanoma 1 | 261
Myocardial Reperfusion Injury 1 | 34
Neoplasm Invasiveness 1 | 127
Neoplastic Cell Transformation 1 | 81
Nerve Degeneration 1 | 73
Pain 1 | 70
Tetanus 1 | 66
Thalassemia 1 | 46
Thrombocytopenia 1 | 105
Toxic shock syndrome 1 | 28
Toxoplasmosis 1 | 16
Type 1 diabetes mellitus 1 | 101
Vaccinia 1 | 37
Vitiligo 1 | 71
fascioscapulohumeral muscular dystrophy 1 | 100
inclusion-cell disease 1 | 15
sarcoidosis 1 | 358
tick-borne encephalitis 1 | 14
uncontrolled asthma 1 | 67

Tissue

Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Male tissues 6 | 17,969
Nervous System 6 | 18,561
Respiratory system 6 | 17,484
Skin and soft tissues 6 | 18,115
Urinary Tract 6 | 18,444
Liver and Pancreas 5 | 18,136

Target Family

Non-IDG 4 | 11,971
Enzyme 2 | 4,146
Transporter 1 | 473

Grant Application

1ZIAHL006060-05 7 | 7
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Transferrin receptor protein 1 TFRC Tbio Non-IDG -3.39868 2437.0 1167
Ubiquitin carboxyl-terminal hydrolase 6 USP6 Tbio Enzyme -1.85768 74.8 140
E3 ubiquitin-protein ligase MARCH8 MARCH8 Tbio Enzyme -1.48289 40.3 104
Interleukin-2 IL2 Tchem Non-IDG -4.34342 23652.7 1173
Putative L-type amino acid transporter 1-like protein MLAS SLC7A5P1 Tdark Transporter -2.14040 135.6 0
Basigin BSG Tchem Non-IDG -3.01524 1224.4 997
CD44 antigen CD44 Tbio Non-IDG -3.80016 6460.0 2499